Who invested in GlySens

3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$14Mraised across 3 rounds since 2012, from 3 sources

$2.0MGrant$12MSeries C

Latest round: Series C, $12MJan 2015
Step-upi: 6×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201320142015

?Round$2.0MGrant$12MSeries C

First round: Round
Biggest round: $12M
Usual gap between rounds: 2.2 years

The rounds

Jan 2015
Series C$12M
No investor was named in the report.
From a historical funding record
Nov 2014
Grant$2.0M1 new
- National Institutes of Health
From a historical funding record
Sept 2012
RoundAmount undisclosed1 new
- West Health Investment Fund
Reported by finsmes.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2012Grant2014Series C2015

National Institutes of Health

West Health Investment Fund

Everyone who backed them

National Institutes of HealthGovernment1round

West Health Investment FundInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists GlySens as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.